ARCHIVES

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

No Link Between Pneumonitis, Taxanes, And Radiation

November 26, 2004

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says

November 4, 1994

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

Tobacco Council awards $10 Million In 1986

August 14, 1987